Panacea Financial is a technology company.
Panacea Financial has raised $62.0M across 2 funding rounds.
Panacea Financial has raised $62.0M in total across 2 funding rounds.
Panacea Financial has raised $62.0M in total across 2 funding rounds.
Panacea Financial's investors include DST Global, Presight Capital, Valar Ventures, Jan Beckers, Mato Peric, Philipp Freise.
Panacea Financial is a financial technology company, operating as a division of Primis Financial Corp. (NASDAQ: FRST), that provides specialized banking and lending solutions exclusively for physicians, medical students, residents, and attendings across all 50 U.S. states, Washington D.C., and Puerto Rico.[1][2][3] It offers products like personal loans up to $75,000 (funded in 24 hours at rates below credit cards), student loan refinancing without cosigner or income limits, commercial loans, free checking with nationwide ATM fee waivers, high-yield savings, and 24/7 live support—all tailored to address the unique financial challenges of medical professionals, such as high student debt and irregular early-career income.[3][5] Backed by Primis Bank, Panacea has raised over $62 million in Series B funding (including $24.5M in 2024 and $37M+ in 2025), signaling strong growth momentum in the fintech space for healthcare pros.[1][4]
The company's mission is to improve doctors' lives by delivering needs-based financial services built by physicians who understand their pain points, from training to practice ownership.[2][3] This focus has driven partnerships like with the Arkansas Medical Society and investments in tech for scalability, positioning Panacea as a digital-first disruptor in physician banking.[3][5]
Panacea Financial was officially launched on November 1, 2020, founded by physicians Michael Jerkins, MD, M.Ed. (President and Co-Founder) and Ned Palmer, MD, MPH (COO and Co-Founder), who identified a critical gap: traditional banks misunderstood doctors' financial needs during training and early careers, often undervaluing them as customers due to deferred income and high debt.[2][3][6] Jerkins and Palmer, drawing from their own experiences, envisioned tailored products and recruited Tyler Stafford—a former bank equity research analyst with deep industry insight—as CEO to execute the vision.[2]
Stafford joined full-time, leaving his role to lead operations, while the team partnered with Primis Bank, a publicly traded institution with billions in assets and a focus on innovation, to provide the banking backbone.[1][2] Early development took nearly three years and $3.5 million, fueled by the founders' shared frustrations and a commitment to physician-centric service.[2][3] Pivotal traction came from exclusive offerings for groups like the Arkansas Medical Society, building a foundation for nationwide expansion.[5]
Panacea's edge lies in its physician-led design, solving pain points ignored by generic banks:
These features create a "bank by doctors, for doctors" model, outperforming undifferentiated competitors.[2][6]
Panacea rides the fintech democratization wave in healthcare finance, targeting a $1T+ U.S. physician debt market amid rising med school costs and clinician shortages.[3][6] Timing is ideal post-2020, as digital banking surged during the pandemic, enabling remote services for mobile residents and rural docs—markets traditional banks underserved.[2] Favorable forces include regulatory tailwinds for embedded finance, Primis's stability amid bank consolidations, and VC interest (e.g., Valar Ventures), fueling Series B extensions into 2025.[1][4]
It influences the ecosystem by strengthening physician pipelines—via debt relief and practice loans—boosting underrepresented minorities and overall med workforce resilience, while modeling niche fintech for pros like dentists/vets.[3][5]
Panacea is poised for explosive growth, leveraging 2025's $37M+ Series B to invest heavily in AI-driven personalization and expansion beyond physicians (e.g., vets, dentists).[1][3][4] Trends like rising healthcare labor demands, AI in lending, and neobank adoption will accelerate its "bank of choice" goal, potentially capturing 10-20% of U.S. docs via viral physician networks.[1][2] Influence may evolve through acquisitions or IPO synergy with Primis, redefining pro banking—proving specialized fintech delivers where incumbents fail, just as its doctor-founders set out to do.[2][6]
Panacea Financial has raised $62.0M across 2 funding rounds. Most recently, it raised $37.0M Series B in July 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2025 | $37.0M Series B | DST Global, Presight Capital, Valar Ventures, Jan Beckers, Mato Peric, Philipp Freise | |
| Jan 1, 2024 | $25.0M Series B | DST Global, Presight Capital, Valar Ventures, Jan Beckers, Mato Peric, Philipp Freise |